Table.
Characteristic | Total Cohort (N = 139) |
Detoxification (n = 67) |
Linkage (n = 72) |
t or χ2 | P Value |
---|---|---|---|---|---|
Age, mean (SD), y | 40.5 (11.8) | 39.6 (11.5) | 41.4 (12.0) | −0.89 | .38 |
Male sex | 99 (71.2) | 48 (72.6) | 51 (70.8) | 0.01 | .92 |
Race/ethnicity | 1.26 | ||||
White | 60 (43.2) | 28 (41.8) | 32 (44.4) | .74 | |
African American | 39 (28.1) | 17 (25.4) | 22 (30.6) | ||
Hispanic | 30 (21.6) | 16 (23.9) | 14 (19.4) | ||
Other | 10 (7.2) | 6 (9.0) | 4 (5.6) | ||
Illicit opioid use per 30 follow-up days, mean (SD), d |
20.8 (9.7) | 20.9 (9.2) | 20.8 (10.3) | 0.11 | .92 |
Previous opioid agonist therapy, d | |||||
Mean (SD) | 57 (41.0) | 25 (37.3) | 32 (44.4) | 0.07 | .39 |
Observed at 1 month | 92 (66.2) | 40 (59.7) | 52 (72.2) | 2.43 | .12 |
Observed at 3 months | 88 (63.3) | 39 (58.2) | 49 (68.1) | 1.45 | .23 |
Observed at 6 months | 82 (59.0) | 32 (47.8) | 50 (69.4) | 6.75 | .009 |
Data are presented as number (percentage) of study participants unless otherwise indicated.